Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why CRISPR Therapeutics Stock Fell 15.9% Last Month and Continues to Fall


CRISPR Therapeutics (NASDAQ: CRSP) stock sank by 15.9% in January, according to data from S&P Global Market Intelligence, amid a surge of bearish momentum impacting the broader market. 

CRSP Chart

CRSP data by YCharts

Continue reading


Source Fool.com

Like: 0
Share

Comments